Addressing vaccine misconceptions essential to increasing vaccination rates during respiratory virus...
By
Kimberly Bonvissuto
Sep 26, 2024
An even greater number of Americans than last year say they don’t plan to vaccinate themselves against COVID-19 or flu this year despite warnings from health experts about severe risks, according to...
Provider associations advise residents to consult with doctors in wake of health officials’ stance...
By
Kimberly Bonvissuto
Sep 17, 2024
Senior living providers in Florida are advising their residents, particularly those with underlying health conditions, to consult their own doctors before making a decision about COVID-19 vaccination,...
Protecting senior living residents from respiratory viruses means educating the community around them
By
Kimberly Bonvissuto
Sep 11, 2024
When it comes to increasing vaccination rates against respiratory viruses, it’s not only important to educate senior living residents about the value of vaccines; it’s also important to educate their...
RSV infection with inflammatory bowel disease ups risk for hospitalization
By
Haymarket Media
Aug 28, 2024
“Adult patients with IBD and RSV infection … may benefit from the new RSV vaccine recommended for adults aged 60 years and older,” the authors write.
FDA approves updated COVID shots for fall
Aug 22, 2024
Updated shots to shield against COVID-19 infection were approved by the US Food and Drug Administration on Thursday.
CDC advises updated COVID vaccine for everyone over 6 months of age
Jun 28, 2024
Americans 65 and older account for two-thirds of COVID hospitalizations and 82% of in-hospital deaths, yet only about 40% of Americans in that age group were immunized with the COVID vaccines that were...
US government to pay Moderna $176 million to develop mRNA flu vaccine
Jul 02, 2024
Such a vaccine could be used to treat bird flu in people, as concern grows about H5N1 cases spreading in dairy cows across the country, the US Department of Health and Human Services (HHS) noted.
SARS-CoV-2 vaccine does not increase new-onset seizure risk
Apr 30, 2024
The findings compared with placebo at 28-day and 43-day follow-up.
No decline in cardiovascular events seen with COVID-19 vaccine after acute coronary syndromes
Jun 03, 2024
Findings show no significant reduction in primary end point, MACE for those receiving vaccine after acute coronary syndromes
Disease severity similar for RSV as unvaccinated COVID-19, influenza
Apr 05, 2024
The odds of invasive mechanical ventilation and death significantly increased for those with RSV versus vaccinated COVID and flu.